Qualium Investissement is acquiring a 25% minority stake in IMPC from its associate radiologists. This primary LBO transaction follows a strategic period of reflection during which the founding doctors chose to maintain operational and capital control of their group rather than pursuing a majority sale. The operation is designed to provide the necessary capital to fund a targeted external growth strategy, particularly in the Paris region, while offering a medical-led alternative to the broader consolidation of the imaging market. A significant portion of the deal structure involves doubling the number of associates to integrate a new generation of radiologists into the group's governance. The transaction is supported by a senior debt facility that includes a substantial capital expenditure line for future acquisitions aimed at reinforcing the group's medical specialties. This partnership emphasizes long-term independence and professional excellence in a rapidly evolving regulatory and financial environment for medical practices.

IMPC (IMAGERIE MEDICALE PARIS CENTRE), which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN discount to the 12.8x average currently observed in the Healthcare & Pharma sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.